Biogen
BIIB
BIIB
946 hedge funds and large institutions have $49.3B invested in Biogen in 2016 Q1 according to their latest regulatory filings, with 95 funds opening new positions, 363 increasing their positions, 350 reducing their positions, and 103 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
946
Holders Change
-22
Holders Change %
-2.27%
% of All Funds
25.25%
Holding in Top 10
32
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-13.51%
% of All Funds
0.85%
New
95
Increased
363
Reduced
350
Closed
103
Calls
$1.05B
Puts
$1.13B
Net Calls
-$73.9M
Net Calls Change
+$323M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
$2.11B |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
$3.51B |
| 3 |
Primecap Management
Pasadena,
California
|
$4.23B |
| 4 |
VAM
Visium Asset Management
New York
|
$99.3M |
| 5 |
Invesco
Atlanta,
Georgia
|
$941M |
